SCHEMBL7778249

SCHEMBL7778249

NS(=O)(=O)c1ccc(-c2n[nH]c(COCc3ccccc3)c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.52
PTGS1 P23219 5/20 0.52
TTK P33981 2/20 0.43
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA9 Q16790 5/20 0.41
CA4 P22748 2/20 0.41
CA5A P35218 2/20 0.41
CA7 P43166 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
CA14 Q9ULX7 2/20 0.40
AR P10275 1/20 0.40
DHFR P00374 1/20 0.40
GHSR Q92847 1/20 0.40
ENPP3 O14638 1/20 0.40
MAPK14 Q16539 1/20 0.40
STAT3 P40763 1/20 0.39
MT-CO2 P00403 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780855 0.89 GHSR (0.46) PTGS2PTGS1ARGHSRMAPK14
SCHEMBL8627791 0.85 PTGS1 (0.42) PTGS2PTGS1TTKCA12CA1
SCHEMBL8759219 0.81 MAPK14 (0.43) PTGS2PTGS1TTKCA12CA1
SCHEMBL8177293 0.81 PTGS2 (0.43) PTGS2PTGS1TTKCA12CA1
SCHEMBL7778142 0.79 PTGS2 (0.48) PTGS2PTGS1TTKCA12CA1
SCHEMBL7779803 0.79 PTGS2 (0.50) PTGS2PTGS1TTKCA12CA1
SCHEMBL7773152 0.77 PTGS2 (0.58) PTGS2PTGS1CA12CA1CA2
SCHEMBL7773228 0.77 PTGS2 (0.55) PTGS2PTGS1CA12CA1CA2
SCHEMBL8627790 0.77 MAPT (0.45) PTGS2PTGS1ARDHFRGHSR
SCHEMBL8759274 0.76 PTGS2 (0.40) PTGS2PTGS1TTKCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed